Applied mathematics for environmental problems

por Asensio, María, Oliver, Albert, Sarrate, José
Publicado 2021

A phenomenological computational model of the evoked action potential fitted to human cochlear implant responses

por Ramos-de-Miguel, Ángel, Escobar, José M., Greiner, David, Benítez, Domingo, Rodríguez, Eduardo, Oliver, Albert, Hernández, Marcos, Ramos-Macías, Ángel
Publicado 2022

Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns

por Mateo, Lidia, Duran-Frigola, Miquel, Gris-Oliver, Albert, Palafox, Marta, Scaltriti, Maurizio, Razavi, Pedram, Chandarlapaty, Sarat, Arribas, Joaquin, Bellet, Meritxell, Serra, Violeta, Aloy, Patrick
Publicado 2020

Ascorbic acid supports ex vivo generation of plasmacytoid dendritic cells from circulating hematopoietic stem cells

por Laustsen, Anders, van der Sluis, Renée M, Gris-Oliver, Albert, Hernández, Sabina Sánchez, Cemalovic, Ena, Tang, Hai Q, Pedersen, Lars Henning, Uldbjerg, Niels, Jakobsen, Martin R, Bak, Rasmus O
Publicado 2021

GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells

por Bellio, Chiara, Emperador, Marta, Castellano, Pol, Gris-Oliver, Albert, Canals, Francesc, Sánchez-Pla, Alex, Zamora, Esther, Arribas, Joaquín, Saura, Cristina, Serra, Violeta, Tabernero, Josep, Littlefield, Bruce A., Villanueva, Josep
Publicado 2022

AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors

por Dunn, Shanade, Eberlein, Cath, Yu, Jason, Gris-Oliver, Albert, Ong, Swee Hoe, Yelland, Urs, Cureton, Natalie, Staniszewska, Anna, McEwen, Robert, Fox, Millie, Pilling, James, Hopcroft, Philip, Coker, Elizabeth A., Jaaks, Patricia, Garnett, Mathew J., Isherwood, Beverley, Serra, Violeta, Davies, Barry R., Barry, Simon T., Lynch, James T., Yusa, Kosuke
Publicado 2022

In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer

por Zagorac, Ivana, Fernandez-Gaitero, Sara, Penning, Renske, Post, Harm, Bueno, Maria J., Mouron, Silvana, Manso, Luis, Morente, Manuel M., Alonso, Soledad, Serra, Violeta, Muñoz, Javier, Gómez-López, Gonzalo, Lopez-Acosta, Jose Francisco, Jimenez-Renard, Veronica, Gris-Oliver, Albert, Al-Shahrour, Fatima, Piñeiro-Yañez, Elena, Montoya-Suarez, Jose Luis, Apala, Juan V., Moreno-Torres, Amalia, Colomer, Ramon, Dopazo, Ana, Heck, Albert J. R., Altelaar, Maarten, Quintela-Fandino, Miguel
Publicado 2018

TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS‐CoV‐2 infection

por van der Sluis, Renée M, Cham, Lamin B, Gris‐Oliver, Albert, Gammelgaard, Kristine R, Pedersen, Jesper G, Idorn, Manja, Ahmadov, Ulvi, Hernandez, Sabina Sanches, Cémalovic, Ena, Godsk, Stine H, Thyrsted, Jacob, Gunst, Jesper D, Nielsen, Silke D, Jørgensen, Janni J, Bjerg, Tobias Wang, Laustsen, Anders, Reinert, Line S, Olagnier, David, Bak, Rasmus O, Kjolby, Mads, Holm, Christian K, Tolstrup, Martin, Paludan, Søren R, Kristensen, Lasse S, Søgaard, Ole S, Jakobsen, Martin R
Publicado 2022

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

por Castroviejo‐Bermejo, Marta, Cruz, Cristina, Llop‐Guevara, Alba, Gutiérrez‐Enríquez, Sara, Ducy, Mandy, Ibrahim, Yasir Hussein, Gris‐Oliver, Albert, Pellegrino, Benedetta, Bruna, Alejandra, Guzmán, Marta, Rodríguez, Olga, Grueso, Judit, Bonache, Sandra, Moles‐Fernández, Alejandro, Villacampa, Guillermo, Viaplana, Cristina, Gómez, Patricia, Vidal, Marc, Peg, Vicente, Serres‐Créixams, Xavier, Dellaire, Graham, Simard, Jacques, Nuciforo, Paolo, Rubio, Isabel T, Dientsmann, Rodrigo, Barrett, J Carl, Caldas, Carlos, Baselga, José, Saura, Cristina, Cortés, Javier, Déas, Olivier, Jonkers, Jos, Masson, Jean‐Yves, Cairo, Stefano, Judde, Jean‐Gabriel, O'Connor, Mark J, Díez, Orland, Balmaña, Judith, Serra, Violeta
Publicado 2018

Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance

por Serra, Violeta, Wang, Anderson T., Castroviejo-Bermejo, Marta, Polanska, Urszula M., Palafox, Marta, Herencia-Ropero, Andrea, Jones, Gemma N., Lai, Zhongwu, Armenia, Joshua, Michopoulos, Filippos, Llop-Guevara, Alba, Brough, Rachel, Gulati, Aditi, Pettitt, Stephen J., Bulusu, Krishna C., Nikkilä, Jenni, Wilson, Zena, Hughes, Adina, Wijnhoven, Paul W.G., Ahmed, Ambar, Bruna, Alejandra, Gris-Oliver, Albert, Guzman, Marta, Rodríguez, Olga, Grueso, Judit, Arribas, Joaquin, Cortés, Javier, Saura, Cristina, Lau, Alan, Critchlow, Susan, Dougherty, Brian, Caldas, Carlos, Mills, Gordon B., Barrett, J. Carl, Forment, Josep V., Cadogan, Elaine, Lord, Christopher J., Cruz, Cristina, Balmaña, Judith, O'Connor, Mark J.
Publicado 2022